Aug. 2 at 12:51 AM
$HYFT At the invitation of the Voka–Limburg Chamber of Commerce, I conducted a summer internship at MindWalk, a company located in the Defense BioVille complex. BioVille is a bio cluster where numerous biotech companies from the Limburg region are gathered.
As the lead negotiator for the new European Biotech Act aimed at strengthening the biotech industry in Europe, I took particular interest in the technologies and innovations that MindWalk is developing using artificial intelligence.
MindWalk's latest innovative technology, ReefIQ, leverages artificial intelligence to integrate data scattered across various global databases, thereby enabling the faster development of new vaccines and medicines. Currently, it commonly takes 10 years, and sometimes up to 15 years, for a single new drug to reach the market.
Through the new biotech act, we seek to shorten this timeline. If ReefIQ's innovative technology is added to this, the entire development process can be dramatically accelerated.
In this process, Europe's regulations must lead to more expedited procedures, which must ultimately benefit European citizens. Gaining faster access to medicines and treatments developed in Europe ultimately means higher survival chances for patients suffering from diseases.
I sincerely thank Dr. Dirk Van Hyfte, Ingrid Brands, and Arnout Van Hyfte for guiding me to directly experience the amazing world of artificial intelligence and biotech.
